Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cachexia × Counseling × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 35 Colorectal Neoplasms 13 Colonic Neoplasms 13 Neoplasms 11 Rectal Neoplasms 10 Carcinoma, Non-Small-Cell Lung 10 Prostatic Neoplasms 9 Lung Neoplasms 8 Obesity 7 Motor Activity 7 Uterine Cervical Neoplasms 6 Small Cell Lung Carcinoma 6 Endometrial Neoplasms 6 Depression 6 Tobacco Use Disorder 5 Pancreatic Neoplasms 5 Overweight 5 Leukemia, Myeloid, Acute 5 Fatigue 5 Sexuality 4 Leukemia 4 Breast Carcinoma In Situ 4 Body Weight Changes 4 Anxiety Disorders 4 Urinary Bladder Neoplasms 3 Unspecified Adult Solid Tumor, Protocol Specific 3 Stomach Neoplasms 3 Sexual Dysfunction, Physiological 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Ovarian Neoplasms 3

Interventions

Megestrol Acetate 9 Exercise 5 Standard of Care 4 Olanzapine 3 Blood Specimen Collection 3 dermcidin 2 anamorelin 2 Resistance Training 2 Physical Therapy Modalities 2 Nutrition Assessment 2 Mirtazapine 2 Infliximab 2 Ibuprofen 2 Enteral Nutrition 2 Dietary Supplements 2 Diet Therapy 2 Cyproheptadine 2 testosterone enanthate 1 telotristat ethyl 1 remune 1 ostarine 1 olanzapine-fluoxetine combination 1 nabiximols 1 nabilone 1 irinotecan sucrosofate 1 fucoidan 1 clazakizumab 1 bermekimab 1 Vitamin D 1 Ultrasonography 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02330926 2025-08-29

MENAC

Norwegian University of Science and Technology

Phase 3 Completed

Cachexia, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡